Profenac

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Profenac

Quick Facts Description
Active ingredient Diclofenac (commonly as sodium or potassium salt)
Form Available as tablets, solutions for injection, and topical gels
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Primary purpose Anti-inflammatory, analgesic, and antipyretic action
Origin Synthetic, derived from Phenylacetic acid

What Type of Medicine is Profenac?

Profenac is a synthetic prescription medicine whose active component is Diclofenac, classifying it as a Nonsteroidal Anti-inflammatory Drug (NSAID). This categorization means the drug is chemically distinct from steroids and operates to moderate specific biological pathways responsible for inflammation. Diclofenac is structurally identified as a Phenylacetic acid derivative, a key chemical classification that defines its specific pharmacological properties within the broad NSAID class. Profenac is designed as a single-ingredient product, differing from combination analgesics.

Diclofenac is a globally recognized substance, with its effectiveness in managing pain and inflammation clinically recognized by international health organizations. Its role as a COX inhibitor distinguishes it from simple pain relievers by targeting the underlying inflammatory process itself.


Profenac's Composition and Range of Forms

The therapeutic efficacy of Profenac is entirely derived from its active ingredient, Diclofenac, commonly formulated as the sodium or potassium salt. This compound is known to function as a potent Cyclooxygenase (COX) inhibitor, which is the basis for its anti-inflammatory action by suppressing the body's production of prostaglandins. The flexibility in its chemical form allows for various specialized preparations, supporting tailored use for different patient needs.

To address a wide range of needs, Profenac is made available in several dosage forms, including oral tablets and capsules, sterile solutions for injection for parenteral administration, and various topical gels or patches for application directly to the skin. The availability of forms for both systemic and localized application is a key differentiating feature, allowing for therapeutic action to be broadly distributed or concentrated on a specific area.


The General Purpose of Profenac

The general purpose of Profenac is to provide relief by suppressing the body's production of inflammatory mediators, yielding three primary therapeutic actions: it is anti-inflammatory, it is analgesic (relieving pain), and it is antipyretic (reducing fever). Clinical evidence confirms Diclofenac's ability to reduce symptoms associated with inflammation across different conditions, such as those related to muscle strains. By regulating the inflammatory process at its source, Profenac effectively reduces the associated swelling and hyper-sensitivity, offering a generalized moderating effect on acute and chronic inflammatory responses.

Regulatory References

  1. (MedlinePlus)

What side effects are possible with Profenac?

Possible Side Effects and Safety Information (Diclofenac)

This section outlines the adverse reactions and safety restrictions for Profenac (Diclofenac), as documented in authoritative governmental regulatory sources.

Serious Safety Warnings

Official regulatory documents include strong warnings regarding two major, potentially fatal risks, which may increase with the duration and dose of treatment:

  • Serious Cardiovascular Thrombotic Events: Increased risk of heart attack (myocardial infarction) and stroke.
  • Serious Gastrointestinal (GI) Events: Increased risk of GI bleeding, ulceration, and perforation of the stomach or intestines, which can occur without warning symptoms.

Frequency-Classified Adverse Reactions

Side effects are categorized by how often they occur according to regulatory data. Common side effects (affecting 1 to 10 users in 100) often involve the gastrointestinal system and nervous system, including nausea, vomiting, diarrhea, indigestion, abdominal pain, headache, and dizziness. Rare and Very Rare reactions affect less than 1 in 1,000 users and include serious events such as:

  • Severe skin reactions (e.g., Stevens-Johnson syndrome, Toxic Epidermal Necrolysis).
  • Severe liver problems (fulminant hepatitis, liver failure).
  • Kidney failure and kidney injury.
  • Blood disorders (e.g., anemia, agranulocytosis).
  • Severe allergic reactions (anaphylactic/anaphylactoid reactions).

Safety Restrictions and Contraindications

Profenac is officially contraindicated (should not be used) in patients with specific conditions due to high risk, including:

  • Active gastrointestinal ulcer, bleeding, or perforation.
  • Severe heart failure (NYHA Class II-IV) or established ischemic heart/arterial/cerebrovascular disease.
  • Known allergy to Diclofenac, Aspirin, or other NSAIDs.
  • The third trimester of pregnancy.

Official guidance emphasizes using the lowest effective dose for the shortest possible duration to minimize potential cardiovascular and gastrointestinal risks.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Profenac (Diclofenac) is a potentially severe event that requires immediate medical attention as mandated by regulatory authorities. A large amount of the medicine can be very harmful to both children and adults. The officially documented overdose manifestations primarily involve the gastrointestinal and central nervous systems.

Documented Overdose Manifestations
Gastrointestinal: Nausea, vomiting (potentially with blood), stomach pain, diarrhea, or signs of possible internal bleeding.
Central Nervous System: Drowsiness, dizziness, severe headache, confusion, unsteadiness, or ringing in the ears (tinnitus).

In severe cases of acute intoxication, the official labeling warns of potential life-threatening outcomes including acute renal failure, seizures, coma, and shock. The elderly population is noted as having an increased frequency and severity of adverse gastrointestinal reactions, such as bleeding, which can be fatal.

Immediate Action Required

Regulators explicitly require patients to seek immediate medical help right away or contact a Poison Control Center for a suspected overdose. Urgent medical attention is necessary if symptoms include chest pain, shortness of breath, weakness, slurred speech, or any signs of severe bleeding. Management is strictly symptomatic and supportive treatment as there is no specific antidote known. Monitoring requirements may include hospital observation of vital signs, blood and urine tests, and an Electrocardiogram (ECG).

Therapeutic Uses of Profenac

What Profenac Treats: Main Uses and Benefits

Profenac (Diclofenac) is used in situations involving certain distressing symptoms. The medication is applied across domains where additional symptomatic support is needed, often associated with inflammatory or irritative states.

It is relevant for easing symptoms that interfere with daily comfort across a range of conditions characterized by periods of heightened symptoms of joint pain, swelling, and stiffness, such as Osteoarthritis and Rheumatoid Arthritis. Profenac is also commonly used to help with symptoms following acute musculoskeletal injuries like sprains and strains, and specific episodic pain flares such as migraine attacks and dysmenorrhea.

It is relevant when supportive symptom management is appropriate for symptoms associated with acute or episodic changes, providing relief that helps patients cope more steadily with difficult episodes. “The medication may be part of symptomatic management for conditions involving heightened symptoms.”

Quick Fact: Symptomatic Relief
Primary Symptoms Symptoms related to physical discomfort and systemic imbalance.
Use Context Applied in scenarios where additional management of discomfort is required.
Patient Benefit Contributes to improved day-to-day comfort and helps maintain a sense of stability when symptoms are more noticeable.

Profenac is applied in addressing symptoms that become more disruptive during flare-ups, providing supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. NIH's comprehensive overview on Diclofenac

Eligibility and Restrictions for Use

Profenac's official eligibility is defined by strict rules established in government regulatory documents (e.g., FDA, EMA SmPC), primarily based on hypersensitivity, cardiovascular status, and organ function.

Contraindicated Populations (Must Not Use)

Eligibility Status Patient Group
Contraindicated Known allergy to diclofenac, aspirin, or any other NSAID (Nonsteroidal Anti-inflammatory Drug).
Contraindicated Active gastrointestinal ulceration, bleeding, or perforation.
Contraindicated Severe hepatic (liver) or renal (kidney) impairment/failure.
Contraindicated Established congestive heart failure (NYHA Class II-IV), ischemic heart disease, or cerebrovascular disease.
Contraindicated Women in the last trimester of pregnancy (at or after 30 weeks gestation).
Contraindicated Treatment of perioperative pain in the setting of CABG surgery.

Restricted and Age-Specific Use

  • Older Adults: Require caution and close monitoring due to an increased risk of serious gastrointestinal and renal events.
  • Children: Safety and effectiveness for most oral formulations are not established in children younger than 12 years.
  • Mid-Pregnancy: Use between 20 and 30 weeks of pregnancy must be limited to the lowest effective dose for the shortest duration possible.
  • Conditional Use: Patients with mild-to-moderate renal or hepatic impairment require close medical surveillance. Use is not recommended for women attempting to conceive or while breastfeeding.

What should I know about interactions with other medicines?

Profenac (Diclofenac) has documented interaction patterns that require close regulatory classification, primarily based on pharmacodynamic and pharmacokinetic effects.

Interaction Restrictions

Co-administration is contraindicated for the treatment of perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) Surgery and in patients with established Cardiovascular (CV) Disease, including Class II-IV heart failure. Co-use with other NSAIDs or Aspirin at analgesic doses is generally not recommended due to an increased risk of serious gastrointestinal events.

Pharmacodynamic and Clearance Effects

Profenac creates a pharmacodynamic reinforcement of bleeding risk when taken concurrently with Anticoagulants (e.g., Warfarin), Antiplatelet Agents, SSRIs, or Oral Corticosteroids. A key exposure-modifying interaction occurs with Lithium and Digoxin, where Profenac reduces their renal clearance, leading to an official elevation of their plasma concentrations. The natriuretic effect of Diuretics may be reduced. Co-administration with ACE Inhibitors or ARBs may result in deterioration of renal function, particularly in the elderly or volume-depleted patients. The medicine's metabolism is primarily mediated by the CYP2C9 enzyme, meaning strong inhibitors of this enzyme can officially increase Profenac’s systemic exposure.

Substance Interactions

The co-consumption of Alcohol (Ethanol) is documented to increase the risk of serious gastrointestinal bleeding. For certain oral forms, the presence of Food may delay the onset of absorption without altering the total extent of absorption.

Mechanism of Action

The core mechanism of Profenac (Diclofenac) is the competitive inhibition of the Cyclooxygenase (COX) enzymes, primarily targeting the inducible COX-2 isoform. This action blocks the active site, preventing the conversion of arachidonic acid into prostanoids like mathbfPGE2, which are key mediators involved in nociception and vascular permeability. This is the central molecular step that modifies the body's inflammatory response pathways. The mechanism also involves ancillary activity in the hypothalamus, where reduced mathbfPGE2 synthesis adjusts the central thermoregulatory set point. Furthermore, Profenac modulates ATP-sensitive potassium channels (KATP channels) in peripheral nerve endings, leading to hyperpolarization and dampening of neural excitability. The mechanistic scope is limited to modulation of mediator synthesis; it does not reverse the chemical events that initiate the physiological response. Inhibition of the constitutive COX-1 enzyme reduces the synthesis of protective prostaglandins, which is a functional trade-off inherent to its mechanism.

Dosage and Administration Information

How to Use Profenac

Profenac (Diclofenac) must be administered using the lowest effective dosage for the shortest duration necessary. The drug is available in oral, parenteral (injection), rectal, and topical forms, each with specific administration rules.

Official Dosing and Administration

Form Route & Frequency Standard Adult Dose Range Special Instructions
Oral (Delayed-Release) 2 to 4 times daily 50 mg to 75 mg per dose; MDD up to 150 mg Swallow whole; do not crush or chew.
Oral (Extended-Release) Once daily 100 mg Swallow whole. Typically taken with or after food.
Oral (Powder) Single-dose (as needed) 50 mg per packet Mix contents with 1 to 2 ounces of water and drink immediately on an empty stomach.
Parenteral (IM/IV) Up to twice daily 75 mg per dose; MDD up to 150 mg Parenteral use is generally limited to two days before switching to oral or rectal forms.
Topical (Gel) 2 to 4 times daily Measured amount (e.g., 2 to 4 g or 40 drops) Apply to clean, dry, intact skin; wash hands after use.

Use Protocols and Adjustments

Tablet Integrity: All coated or modified-release tablets and capsules must be swallowed whole to preserve their intended drug release profile. They are not bioequivalent and should not be interchanged.

Preparation for Injection: The solution for intravenous infusion must be diluted with a buffer solution (e.g., sodium bicarbonate in saline) and administered as a slow, controlled infusion, never as a rapid bolus injection.

Population Dosing: Older adults should be started on the lowest effective dosage. Dosing adjustment for patients with mild to moderate renal impairment is typically not necessary for the unchanged drug due to its elimination pathway.

Recent Clinical Evidence

Research evidence / Overview of studies for Profenac

Evidence for use in Chronic Inflammatory Joint Conditions

The research exploring Profenac's use in chronic joint conditions, such as Osteoarthritis (OA) and Rheumatoid Arthritis (RA), has been established through numerous clinical trials. Researchers have utilized extensive Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews to explore how symptoms change over time in these conditions. These studies were designed to measure outcomes related to physical discomfort and daily functioning.

For both OA and RA, data show patterns related to the monitored outcomes linked to inflammatory states. Studies report how symptoms evolved in the observed populations during the study period, including patient-reported outcomes describing perceived discomfort. However, the findings related to functional improvement, especially with topical forms of the medicine, were mixed across different trials, indicating varying results in the research landscape.


Evidence for use in Acute Musculoskeletal and Episodic Pain

Research has explored Profenac's use in various acute and episodic pain situations, including conditions associated with acute or disruptive episodes, such as sprains, muscle strains, migraine attacks, and primary dysmenorrhea. These studies mostly consist of short-term RCTs comparing the medicine to a placebo over a very limited time interval.

In these acute settings, researchers examined outcomes describing episodic or acute changes. Studies conducted during periods of increased symptom activity reported measurements showing patterns of change in outcomes related to physical discomfort during the short follow-up period. For instance, findings for migraine and dysmenorrhea indicate patterns related to the changes observed in acute pain and associated symptoms.


Long-term Studies and Follow-up Duration ⏳

Information regarding the durability of response and continuous usage patterns is derived from post-marketing surveillance and long-term observational cohorts. These studies help show what has been observed so far in real-world conditions but are subject to limitations inherent in non-randomized research. Research reviews highlight that certainty remains low regarding the full range of effects from continuous use over many years, and long-term effects are not fully established.


Understanding the Research Gaps and Uncertainties

While Profenac has been widely studied, regulatory reviews and systematic analyses highlight several areas where certainty remains low. The follow-up durations were limited in many initial RCTs, meaning there is limited information for long-term outcomes that may arise from chronic use. Research does not determine whether an individual will respond similarly to the group findings; the evidence highlights what is known — and what is still uncertain. The impact of the drug class on certain aspects of cardiovascular health remains an area of continuous, focused monitoring and research.

Frequently Asked Questions (FAQ)

Common questions about Profenac (FAQ)

Q: Is Profenac the same kind of drug as ibuprofen or naproxen?

Official sources classify Profenac (Diclofenac) as a Nonsteroidal Anti-inflammatory Drug, or NSAID. This places it in the same general classification group as ibuprofen and naproxen. While they share this classification, each specific drug has its own distinct chemical properties, dosing forms, and established indications.


Q: What is the main difference between Profenac and other similar pain relievers?

Profenac is chemically defined as a phenylacetic acid derivative, which is a specific type of NSAID. Regulatory documents outline its particular systemic absorption profile, established uses, and safety warnings within the broad NSAID class. Differences exist in terms of its specific indications and forms available, which distinguish it from other pain relievers.


Q: Is Profenac used for long-term conditions, or just short-term relief?

Profenac has established indications for managing symptoms related to both chronic conditions, such as certain types of arthritis, and for acute, short-term pain relief. Official guidance generally emphasizes the use for the shortest duration possible to help minimize potential risks.


Q: Can Profenac be taken with common over-the-counter pain medications?

Official warnings advise against the co-administration of Profenac with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) or with Aspirin when used for pain relief. This is because combining them significantly increases the risk of serious gastrointestinal bleeding. If you are taking other medications, it is important to check the official drug interaction guidance.


Q: How quickly does Profenac usually start working for pain?

According to regulatory clinical pharmacology data, for some oral forms, the concentration of the medicine reaches its highest level in the blood—which is consistent with when therapeutic effect is often observed—typically within 1 to 2 hours after administration.


Q: How long does the effect of Profenac typically last after taking it?

The compound's half-life in the bloodstream is short, usually around 1 to 2 hours. This means the compound is quickly cleared from the systemic circulation, although the overall therapeutic effects on inflammatory mediators may be observed for a longer period of time.


Q: Are there any specific foods or drinks that should be avoided when taking Profenac?

Official regulatory labels specifically warn that consuming alcohol while taking Profenac increases the risk of serious gastrointestinal bleeding. For certain oral forms, it is noted that the presence of food may delay the rate at which the medicine is absorbed.


Q: What is the difference between immediate-release and extended-release forms of Profenac?

The immediate-release forms are designed for quick action and are typically dosed multiple times daily to treat acute pain. In contrast, extended-release forms are designed for a slower, continuous release, often allowing for once-daily dosing to manage chronic conditions.


Q: Is feeling dizzy or drowsy a normal side effect of Profenac?

Official regulatory documents commonly list dizziness as a potential side effect. Drowsiness (somnolence) is generally listed as a less frequent or uncommon side effect noted in clinical trials.


Q: If I miss a dose of Profenac, what is generally suggested?

Patient information guides typically describe taking the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the advice is generally to skip the missed dose and resume the normal schedule. No extra medicine should be taken to make up for a missed dose.


Q: How long does Profenac stay in the body after the last use?

The half-life of Profenac in the bloodstream is short, roughly 1 to 2 hours. The total time needed for the body to fully eliminate the compound is dependent on individual metabolism.


Q: Are there certain age groups where Profenac is used less often?

Regulatory documents indicate caution and close monitoring are required for older adults due to increased risks, often starting them at the lowest dose. Additionally, the safety and effectiveness for most oral forms are not established in children younger than 12 years.


Q: What organs in the body does Profenac mainly affect?

Profenac’s primary safety warnings and adverse reaction profiles focus on the gastrointestinal tract and the cardiovascular system. The medicine is also processed by and potentially affects the liver and kidneys, which are important organs for elimination and function.


Q: What is the risk of Profenac causing an allergic reaction?

Official documents explicitly contraindicate the use of Profenac in anyone with a known allergy to it, Aspirin, or any other NSAID. While rare, severe allergic reactions, known as anaphylaxis, are listed among the serious adverse events observed.


Q: Are there any warnings about using Profenac before or after surgery?

Profenac is formally contraindicated for the treatment of pain following Coronary Artery Bypass Graft (CABG) surgery. General warnings also mention an increased risk of bleeding, which is an important consideration for any surgical procedure.


Q: What is the evidence supporting the use of Profenac for arthritis?

Clinical trials and systematic reviews have established evidence that Profenac is associated with modified outcomes related to physical discomfort and inflammation in people with Osteoarthritis and Rheumatoid Arthritis. The data indicates patterns of change in patient-reported outcomes during study periods.


Q: Why are some people told they cannot use Profenac?

Regulatory documents list specific contraindications, which are conditions where the drug must not be used due to established medical risks. These typically include active gastrointestinal bleeding, severe heart failure, or established organ failure (liver, kidney) that could be worsened by the medicine.


Q: What happens if I stop taking Profenac suddenly?

Profenac is not associated with dependency, and stopping the medicine does not typically lead to physical withdrawal symptoms. Discontinuation would generally result in the return of the pain, inflammation, or other symptoms the drug was being used to address.


Q: Does Profenac lose effectiveness over time if taken regularly?

Official regulatory documents do not generally report that patients develop tolerance (reduced effectiveness) to Profenac’s anti-inflammatory or analgesic effects over time with continuous use.


Q: Can Profenac be used for managing fevers?

One of Profenac’s documented pharmacological actions is antipyretic, meaning it has the ability to reduce fever. However, its formal indications for use may vary by region and formulation.


Q: Can Profenac be used by athletes for sports-related injuries?

Profenac has official indications for the management of acute musculoskeletal conditions. This category includes common injuries such as sprains and strains, which are often associated with athletic activity.


Q: Is Profenac a controlled substance or addictive in any way?

Profenac is not classified as a controlled substance by government drug agencies and is not associated with the risk of addiction or dependence.


Q: What research exists about Profenac's use in dental pain?

Official documents in certain regulatory regions list post-operative dental pain as an approved indication. Clinical studies have demonstrated its effectiveness in managing pain following dental procedures.


Q: What is the scientific basis for how Profenac reduces pain signals?

The mechanism of action involves the inhibition of Cyclooxygenase (COX) enzymes. This action reduces the body's production of prostaglandins, which are signaling molecules that are key mediators of pain and inflammation.


Q: Does Profenac contain any ingredients that might cause a reaction in people with sensitivities?

Regulatory labels for all formulations list both the active ingredient (Diclofenac) and all inactive ingredients, such as dyes, excipients, and fillers, used in the product. This information is available to identify potential sensitizing components.


Q: What are the signs of a serious, but rare, side effect of Profenac?

Regulatory patient guides describe serious symptoms that regulatory patient guides indicate should prompt attention. These can include signs like unusual bleeding or black/tarry stools (GI events), severe chest pain or slurred speech (CV events), and yellowing of the skin or eyes (liver events).


Q: Does Profenac affect fertility or reproductive health?

Official regulatory information indicates that Profenac may impair female fertility. It is not generally recommended for women who are actively attempting to conceive.


Q: Is Profenac used in pediatric patients, and if so, for what conditions?

Safety and effectiveness are generally not established for most oral forms in children under 12 years. However, some specialized forms, such as topical gels, may have specific, approved indications for pediatric patients in certain regulatory regions.


Q: Does Profenac have an effect on sleep patterns?

Profenac’s adverse reaction profile includes central nervous system effects such as dizziness and headache. However, direct, specific effects on overall sleep patterns are not generally listed as a common side effect in regulatory documents.


Q: Why do official documents advise caution when using Profenac with diuretics?

Caution is advised because Profenac may cause the retention of sodium and water in the body. This can potentially reduce the effectiveness of diuretics (water pills) and increase the risk of worsening kidney function.


Q: Do other medications need to be stopped before starting Profenac?

Patient safety information generally advises disclosing all current prescription and non-prescription medications to a healthcare provider before starting Profenac. This allows for a review of potential drug interactions and to determine if any medication adjustments are needed.


Q: Can Profenac be used to treat swelling in joints?

Profenac is formally classified as an anti-inflammatory drug. It is indicated for conditions like arthritis where its function is to reduce the underlying inflammation, which is the process that contributes to joint swelling.

How should Profenac be stored and disposed of?

Storage and Disposal of Profenac (Diclofenac)

Profenac must be stored according to official regulatory labeling to ensure its stability.

Mandatory Storage Conditions

Requirement Official Condition
Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F).
Environment Keep away from heat, moisture, and direct light; avoid freezing topical forms.
Protection Must be kept out of the reach of children and pets.
Container Store in a closed container.

Official Disposal Instructions

Unused or expired Profenac should be disposed of via a drug take-back program. If no program is available, the medicine must be emptied from its container, mixed with an undesirable substance (such as dirt or used coffee grounds), sealed in a bag, and then placed in the household trash. Do not keep outdated medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Profenac found in:

A-Z Index: